期刊文献+

2型糖尿病患者血浆ET、血清IL-6、TNF-α变化的临床意义 被引量:5

Clinical Significance of Changes of Plasma Concentration of Endothelium and Serum Levels of Interleukin-6 and Tumor Necrosis Factor in Patients with type 2 Diabetes Mellitus
暂未订购
导出
摘要 目的 :探讨 2型糖尿病患者血浆内皮素 (ET)、白介素 - 6 (IL - 6 )、肿瘤坏死因子 (TNF -α)在糖尿病发生、发展过程中的浓度变化及相互关系。方法 :用放射免疫分析检测 6 1例 2型糖尿病患者及 33例年龄和性别相匹配的健康志愿者血清ET、IL - 6、TNF -α的水平。结果 :① 2型糖尿病患者血中ET、IL - 6、TNF -α水平明显高于正常对照组 (p <0 0 1) ;②有合并症患者血清ET、TNF -α水平明显高于单纯糖尿病患者 (p <0 0 2 ) ;③三种细胞因子间浓度水平呈正相关 (p<0 0 1)。结论 :细胞因子ET、IL - 6、TNF -α在糖尿病的发生、发展过程中相互作用 ,观察其浓度变化对探讨糖尿病的发病机理、预防及指导用药均有重要价值。 Objective To determine the changes of plasma endothelium (ET) and serum interleukin-6 (IL-6) and tumor necrosis factor (TNF-α) concentrations in patients with type 2 diabetes mellitus. Methods Plasma ET and serum IL-6 and TNF-α levels were measured by radioimmunoassy in 61 cases of type 2 diabetes mellitus (DM) 36 without complication and 25 cases with complications and 33 controls. Results (1) The plasma levels of ET and serum levels of IL-6 and TNF-α in patients with type 2 diabetes mellitus were significantly higher than those in the controls ( p <0 01); (2) The blood levels of ET, TNF-α in patients with complications were significantly higher than those in patients without complications ( p <0 02); (3) The blood levels of ET, IL-6 and TNF-α were mutually positively correlated. Conclusion Moritoring of ET,IL-6 and TNF-α levels in diabetic patients can provide additional valuable information for assessing the course of disease and efficacy of management.
出处 《放射免疫学杂志》 CAS 2003年第3期142-144,共3页 Journal of Radioimmanology
关键词 2型糖尿病 血浆 ET 血清 IL-6 TNF-α 内皮素 白介素-6 肿瘤坏死因子 放射免疫分析 type 2 diabetes mellitus, cytokine, endothelim, interleukin-6, tumor necrosis factor
  • 相关文献

参考文献6

二级参考文献31

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2127
  • 2孙林,曾丽霞,叶任高,王斌,肖定章.白细胞介素6反义RNA对肾小球系膜细胞的影响[J].中华肾脏病杂志,1997,13(1):6-9. 被引量:8
  • 3[1] Espersen GT, Mathiesen O, Grunnet N, Jensen S et al. Cytokine plasma levels and lymphocyte subsets in patient withnewly diagnosed insulin-dependent (type 1)diabetes mellitus before and following initial insulin treatment[J]. APMIS, 1997; 101(6):703-706.
  • 4[2] Thomas MP, Hemming P, Jens M et al. Monokine antagonism is reduced in patients with IDDM[J]. Diabetes, 1994; 43(10):1242-1247.
  • 5[3] Molvig, Bak L,Christensen P et al. Endotoxin-stimulated human monocyte secretion of interleukin-1, tumur necrosis factor alpha, and prostaglandin E2 shows stable interindividual difference[J]. Scand J Immunol, 1988; 27(6):705-716.
  • 6[4] Harrsion LC, Honeyman MC, De Aizpurua HJ et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subject at risk of insulin-dependent diabetes[J]. Lancet, 1993; 341(5):1365-1369.
  • 7[5] Foulis AK, McGill M,Farquharson MA. Insulitis in type 1 (insulin-γ dependent)diabetes mellitus in man: Macrophages,lymphocytes,and interferon-γ containing cells[J]. J Pathol, 1991;165(2):97-103.
  • 8[6] Kroemer G, Wick G. The role of interleukin-2 in autoimmunity [J]. Immunol Today, 1989; 10(2):245-251.
  • 9[7] Kolb H, Zielasek J, Treichel U et al. Recombinant interleukin-2 enchanced spontaneous diabetes in BB rat[J]. Eur J Immunol, 1986; 16(2):209-212.
  • 10[8] Seino H, Takahashi K, Satoh J et al. Prevention of autoimmune diabetes with lymphotoxin in NOD mice[J]. Diabetes, 1993; 42(3):398-404.

共引文献152

同被引文献51

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部